To determine whether changing paternity affects the risk of preeclampsia or eclampsia in the subsequent pregnancy and whether the effect depends on a woman's history of preedampsia/eclampsia with her previous partner, a cohort study was conducted based on 140,147 women with two consecutive births during 1989-1991 identified through linking of annual California birth certificate data. Among women without preeclampsia/eclampsia in the first birth, changing partners resulted in a 30% increase in the risk of preeclampsia/eclampsia in the subsequent pregnancy compared with those who did not change partners (95% confidence interval: 1.1,1.6). On the other hand, among women with preeclampsia/eclampsia in the first birth, changing partners resulted in a 30% reduction in the risk of preeclampsia/eclampsia in the subsequent pregnancy (95% confidence interval: 0.4, 1.2). The difference of the effect of changing paternity on the risk of preeclampsia/eclampsia between women with and those without a history of this condition was significant (p < 0.05 for the interaction term). The above estimates were adjusted for potential confounders. These findings suggest that the effect of changing paternity depends on the history of preeclampsia/eclampsia with the previous partner and support the hypothesis that parental human leukocyte antigen sharing may play a role in the etiology of preeclampsia/eclampsia. Am J Epidemiol 2000; 151:57-62. HLA antigens; paternity; preeclampsia; risk factors; vital statistics Preeclampsia, characterized by sustained hypertension with proteinuria occurring after 20 weeks' gestation and spontaneous resolution after delivery (1), is one of the most common pregnancy disorders and a leading cause of maternal mortality (2, 3). The consequences of preeclampsia also include preterm delivery and intrauterine growth retardation, resulting in high perinatal mortality. Preeclampsia, along with eclampsia, a more severe form of preeclampsia, occurs in roughly 3 percent of all deliveries (4). Despite its serious impact on maternal and fetal health, its etiology is still largely unknown.
Preeclampsia, characterized by sustained hypertension with proteinuria occurring after 20 weeks' gestation and spontaneous resolution after delivery (1) , is one of the most common pregnancy disorders and a leading cause of maternal mortality (2, 3) . The consequences of preeclampsia also include preterm delivery and intrauterine growth retardation, resulting in high perinatal mortality. Preeclampsia, along with eclampsia, a more severe form of preeclampsia, occurs in roughly 3 percent of all deliveries (4) . Despite its serious impact on maternal and fetal health, its etiology is still largely unknown.
Preeclampsia is predominately a condition of the first birth. The risk decreases substantially among multiparous women. However, it has been reported that this seemingly protective effect of parity disappears if a parous woman changes her partner (5) (6) (7) (8) (9) . In addition, women who consistently used barrier contraceptives or who were with the partner for a shorter period of time have been reported to be at increased risk of preeclampsia compared with those who did not use barrier contraceptives or who were with the partner for a longer period (10, 11) . These findings suggest that maternal exposure to paternal semen may play an important role in the etiology of preeclampsia. These characteristics have led to the hypothesis of immunogenetic factors in the etiology of preeclampsia (1, 12) , although the underlying mechanisms remain unclear.
In recent years, one of the most important advances in reproductive immunology was the discovery that parental sharing of human leukocyte antigens (HLA) may be associated with adverse pregnancy outcomes (13) (14) (15) . This finding is consistent with our knowledge that inbred mating is associated with deleterious reproductive outcomes. It is now generally recognized that to sustain a pregnancy without rejecting the fetus that carries alloantigens, a mother needs to establish immunologic tolerance. Although still not well understood, the tolerance is probably initiated by fetal (via paternal) immunologic stimulation. Parental HLA sharing results in a lack of adequate antigenic stimulation and failure to establish the maternal immune tolerance, which could lead to a series of adverse pregnancy outcomes ranging from infertility, recurrent spontaneous abortions, and low birth weight to neural tube defects (13) (14) (15) (16) (17) (18) (19) (20) (21) . The strongest evidence derives from the asso-ciation between parental HLA sharing and recurrent spontaneous abortions. Clinical immunologic therapies that help couples with recurrent spontaneous abortions to achieve a successful pregnancy have been implemented, and their effectiveness has been demonstrated in many randomized multicenter clinical trials (22) (23) (24) .
Preeclampsia is considered to be a disease of the placenta, which is at the center of the maternal-fetal immunologic interchange. Parental HLA sharing has also been hypothesized to be a potential underlying mechanism for preeclampsia (25, 26) . However, only limited clinical studies have examined this hypothesis (26) (27) (28) (29) (30) , and results are not consistent (31, 32) . To study this hypothesis further, we conducted a populationbased study using changing paternity as a surrogate measure of changing parental HLA sharing. Women with preeclampsia in the first pregnancy were hypothesized to have a high likelihood of sharing HLA antigens with their partners. Thus, those who changed partners were postulated to reduce the likelihood of sharing HLA antigens with their new partners compared with those who remained with the same partners. The risk of preeclampsia/eclampsia in the subsequent pregnancy was then compared between women who did and those who did not change partners. If parental HLA sharing is associated with the increased risk of preeclampsia, one would expect to see a reduced risk of preeclampsia among those who changed partners. On the other hand, women without preeclampsia in the first pregnancy were hypothesized to have a low likelihood of sharing HLA antigens with their partners. Thus, those who changed partners were postulated to increase the likelihood of sharing HLA antigens with their new partners compared with those who remained with the same ones. Consequently, one would expect to see an increased risk of preeclampsia in the subsequent pregnancy among those who changed partners.
MATERIALS AND METHODS
The study was based on women with two consecutive births during 1989-1991 identified through Unking annual California birth certificate data. The data linkage was based on the combination of deterministic and probabilistic linkage that has been widely used in linking vital statistics data in many other states and countries (33) . First, maternal information from each record was used to match exactly on maternal birth year, state of birth, and maiden and first names. The Linked records were further matched through the probabilistic linkage on maternal day and month of birth and on race/ ethnicity (23 categories). Only those records that had a matching probability of at least 95 percent for maternal day and month of birth and 90 percent for race/ethnicity were included in the study. Linked records with an interval between two birthdays of less than 20 weeks were excluded. Because multiple births may have a different etiologic pathway for preeclampsia than does a singleton birth, the analysis was restricted to women with two consecutive singleton births.
The mother for the two linked birth certificates that met all above matching criteria was considered to have given birth two consecutive times (not necessarily the first two births for the woman) during the 3-year period from 1989 to 1991. Whether a woman changed her partner between the two births was determined by comparing fathers' names recorded on the two linked birth certificates. If the paternal surname or date of birth matched exactly on the two linked birth certificates, the two pregnancies were considered to have been by the same father. Otherwise, the two pregnancies were considered to have been by different fathers. Records with missing data for paternal surname and date of birth (4.1 percent) were excluded.
Preeclampsia and eclampsia abstracted from medical records were recorded on the birth certificate under both pregnancy and labor complications and procedures. Because eclampsia is a severe form of preeclampsia (12) and had an incidence of less than 0.1 percent in the study population, all eclampsia cases were combined with preeclampsia cases in this study. Hereafter, preeclampsia refers to both preeclampsia and eclampsia cases. Linked records with missing data for either pregnancy complications or labor complications were excluded from the study (<0.3 percent).
The odds ratio and 95 percent confidence interval were used to estimate the relative risk after adjustment for potential confounders. The relative risk of preeclampsia associated with changing partners was estimated separately for women with and those without prior preeclampsia by using logistic regression to control for confounders. The variables included in the model were based on available information on known risk factors for preeclampsia, the stratification variable, and commonly adjusted demographic characteristics.
RESULTS
A total of 140,147 women with two consecutive births during the period 1989-1991 were included in the final analysis. About 2 percent of the women reported preeclampsia in the first birth, while 0.9 percent reported preeclampsia in the second.
The comparison of characteristics of the second birth between women who did and those who did not change partners between the two births is presented in Among women without preeclampsia in the first birth, changing partners resulted in a 30 percent increase in risk of preeclampsia in the subsequent birth compared with those who remained with the same partners (odds ratio (OR) = 1.3, 95 percent confidence interval (CI): 1.1, 1.6). On the contrary, among women with preeclampsia in the first birth, changing partners led to a 30 percent reduction in the risk of preeclampsia in the subsequent birth relative to women who did not change partners (OR = 0.7, 95 percent CI: 0.4, 1.2). This difference in the effect of changing partners on the risk of preeclampsia in the subsequent pregnancy between women with and those without prior preeclampsia was statistically significant (p < 0.05 for the interaction term). The above estimates were adjusted for maternal age, parity, maternal race/ethnicity, educational level, the gestational month of initial prenatal visit, prenatal smoking, and infant sex (table 2) . Further adjustment for a history of miscarriage and the interval from the first birth to the conception of the index pregnancy did not change the results.
DISCUSSION
Some limitations of the study need to be kept in mind when interpreting the results. Because the study was based on birth certificate data, the ascertainment of preeclampsia/eclampsia may not have been complete. Although it varies depending on parity and racial composition of the population, the incidence of preeclampsia has generally been reported to be around 3 percent (4). The incidence of preeclampsia/eclampsia in the first birth in this population was about 2 percent, indicating a potential underreporting. However, for it to have biased the results, the potential underreporting not only had to have been associated with changing partners, but also to have biased the estimate downward among women with prior preeclampsia and upward among women without prior preeclampsia (table 2) . Otherwise, the potential underreporting would only have resulted in an attenuation of the true association. In other words, the observed associations would have been even stronger without the underreporting. Although misdiagnosed preeclampsia may also exist, this potential misclassification is unlikely to be significant because preeclampsia recorded on the birth certificate was based on medical records. To the extent that the problem existed, the effect would also have resulted in an attenuation of the true association.
The underreporting could also exist for potential confounders, such as prenatal smoking. In addition, information on some potential confounders, such as obesity and diabetic condition, was not available from the birth certificates. Fortunately, information on most known risk factors for preeclampsia was available for adjustment (parity, age, and race/ethnicity) or stratification (prior preeclampsia). Therefore, the residual confounding effect, if any, should be limited. Furthermore, any residual confounding effect is unlikely to explain why the effect of changing partners on the risk of subsequent preeclampsia differed between women with and those without prior preeclampsia. For the potential confounders to explain the findings, they would have had to bias the effect in opposite directions depending upon a woman's history of preeclampsia.
Because of the availability of data, only women who delivered two births within 3 years of the study period were included. Although this population may be different in many aspects when compared with those whose birth interval is more than 3 years, the interval between the previous birth and the conception of the second birth was not associated with the risk of preeclampsia in this study population (OR = 1.0, 95 percent CI: 0.95, 1.09). Therefore, not including * OR, odds ratio; CI, confidence interval. t Adjusted for maternal race/ethnicity, age, educational level, prenatal smoking, gestational month of initial prenatal visit, parity, and interval between previous birth and conception of the index pregnancy.
women whose birth interval was more than 3 years is unlikely to have biased the results. In addition, the potential effect of birth interval, if it existed, was unlikely to have influenced the association between changing paternity and the risk of preeclampsia because the association was observed among women with a similar birth interval. The short birth interval of the study population, however, does have a potential to limit the generalizability of the results if the association should later be demonstrated to exist only among women with a short birth interval.
Although the accuracy of changing partners based on the linkage could not be examined directly, the proportion of woman who changed partners between the two births based on the linkage (9.7 percent) was similar to the 9.9 percent reported in a study conducted in California in which the information on changing partners was ascertained through in-person interview (7) .
Immunologic mechanisms in the etiology of preeclampsia have long been hypothesized, but previous studies of the effect of changing partners were focused on the hypothesis that fresh antigens from new partners were a risk factor for preeclampsia (5) (6) (7) (8) (9) . However, our findings do not seem to support this hypothesis. Although changing partners did increase the risk of preeclampsia in the subsequent pregnancy among women without a history of preeclampsia, having a new partner actually decreased the risk of preeclampsia among women with a history of preeclampsia (table 2) . This indicates that the fresh paternal antigens themselves do not constitute a sufficient cause. Other maternal and/or paternal factors may play an important role in the etiology of preeclampsia. One of these factors could be parental HLA sharing, which impairs the establishment of maternal immune tolerance that is needed to sustain a successful pregnancy. In a couple without HLA sharing, a prior livebirth should provide an enhanced protection against the risk of preeclampsia in a future pregnancy fathered by the same partner. This has been hypothesized to be due to the maternal immune tolerance to a similar fetus (sibling) established during a prior pregnancy that was greatly enhanced during delivery because of the exposure to high levels of fetal antigens (25) . Therefore, when a parous woman changes partners, the protective effect offered by the previous pregnancies no longer exists; thus, her risk of preeclampsia in a pregnancy fathered by a new partner is higher than that of a woman who remains with the same partner. The reported increased risk of preeclampsia associated with changing partners in many previous studies may have reflected this phenomenon among women without parental HLA sharing because they comprised the majority of those study populations (5-9).
On the contrary, if a woman had prior preeclampsia, thus indicating her sharing of HLA antigens with her current partner, her ability to establish the protective immune tolerance would be limited due to the lack of immunologic stimulation resulting from HLA sharing. Therefore, prior livebirths in this case would not provide as much protection as that among women without HLA sharing. In fact, changing a partner, which likely results in less HLA sharing, would reduce the risk of preeclampsia because of the enhanced immunologic stimulation from the fetus fathered by the new partner. The results in table 2 support this hypothesis. Although no epidemiologic studies have been reported to have examined the effect of changing partners based on the hypothesis of HLA sharing, the finding that changing partners decreased the risk of preeclampsia among women with a history of preeclampsia while it increased the risk among women without a history of preeclampsia was reported in a recent publication (9) .
An alternative explanation for the observed effect of changing partners on the risk of preeclampsia in the subsequent pregnancy would be paternally related factors, genetic or otherwise. In other words, a small proportion of men in the general population may carry a higher risk of fathering a pregnancy with preeclampsia. Thus, changing partners after preeclampsia would reduce the risk of preeclampsia in future pregnancies. However, the paternal factor is unlikely to be the only determinant of preeclampsia without the involvement of maternal factors. In fact, the finding of this study indicates that maternal factors play a more important role. If a paternal factor were the sole determinant of preeclampsia, one would have expected the risk to be similar among women who changed partners (assuming random mating), regardless of their history of preeclampsia. However, after changing partners, the risk of preeclampsia was still much higher among women with a history of preeclampsia (6.4 percent) than among women without such a history (0.9 percent) (table 2). One of the potential mechanisms for this maternal importance could be that a history of preeclampsia is a marker for women who do not respond to fetal immunologic stimulation as strongly as do women without a history, and, thus are less likely, under the same fetal stimulation, to establish the immune tolerance needed for a successful pregnancy. The failure in establishing immune tolerance to protect pregnancy could make the women more susceptible to various adverse pregnancy outcomes, including preeclampsia. Women who responded poorly to paternal immune stimulation have been reported among women with recurrent spontaneous abortions (13) . Therefore, a history of preeclampsia may be a marker for identifying those women who have a reduced capacity of reproductive immune responses, and, thus, are at higher risk of preeclampsia, although HLA sharing would exacerbate the poor response.
If parental HLA sharing is associated with an increased risk of preeclampsia, a couple who is at higher risk of preeclampsia could be identified through HLA typing. If the immunologic therapies used in treating recurrent spontaneous abortions are as effective as demonstrated in many randomized clinical trials, this could have a large impact on reducing the incidence of preeclampsia, thus reducing maternal mortality and improving pregnancy outcomes.
